These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 26491298)
1. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. Abdelbary AA; Al-mahallawi AM; Abdelrahim ME; Ali AM Int J Nanomedicine; 2015; 10():6339-53. PubMed ID: 26491298 [TBL] [Abstract][Full Text] [Related]
2. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery. Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643 [TBL] [Abstract][Full Text] [Related]
3. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation. Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321 [TBL] [Abstract][Full Text] [Related]
4. Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation. Geng T; Banerjee P; Lu Z; Zoghbi A; Li T; Wang B Eur J Pharm Sci; 2017 Nov; 109():200-208. PubMed ID: 28811130 [TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Devrim B; Bozkır A; Canefe K Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727 [TBL] [Abstract][Full Text] [Related]
6. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity. Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259 [TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of mucoadhesive buccal films impregnated with carvedilol nanosuspension: a potential approach for delivery of drugs having high first-pass metabolism. Rana P; Murthy RS Drug Deliv; 2013; 20(5):224-35. PubMed ID: 23651066 [TBL] [Abstract][Full Text] [Related]
8. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Zhang Y; Zhi Z; Li X; Gao J; Song Y Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816 [TBL] [Abstract][Full Text] [Related]
9. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance. Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860 [TBL] [Abstract][Full Text] [Related]
10. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. Saindane NS; Pagar KP; Vavia PR AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198 [TBL] [Abstract][Full Text] [Related]
11. Dry powder inhalation formulation of chitosan nanoparticles for co-administration of isoniazid and pyrazinamide. Changsan N; Sinsuebpol C Pharm Dev Technol; 2021 Feb; 26(2):181-192. PubMed ID: 33213232 [TBL] [Abstract][Full Text] [Related]
12. Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery. Mehanna MM; Mohyeldin SM; Elgindy NA Int J Nanomedicine; 2019; 14():9089-9112. PubMed ID: 31819421 [TBL] [Abstract][Full Text] [Related]
13. In silico-in vitro-in vivo studies of experimentally designed carvedilol loaded silk fibroin-casein nanoparticles using physiological based pharmacokinetic model. Kumar S; Singh SK Int J Biol Macromol; 2017 Mar; 96():403-420. PubMed ID: 28013012 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery. Varshosaz J; Hassanzadeh F; Mardani A; Rostami M Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091 [TBL] [Abstract][Full Text] [Related]
15. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability. Liu D; Xu H; Tian B; Yuan K; Pan H; Ma S; Yang X; Pan W AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736 [TBL] [Abstract][Full Text] [Related]
16. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation. Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985 [TBL] [Abstract][Full Text] [Related]
17. Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance. Ezzati Nazhad Dolatabadi J; Hamishehkar H; Valizadeh H Drug Dev Ind Pharm; 2015; 41(9):1431-7. PubMed ID: 25220930 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-containing lyophilized dry powder inhaler formulations optimized using central composite design with improved aerodynamic parameters and redispersibility. Akdag Y Pharm Dev Technol; 2023 Jan; 28(1):124-137. PubMed ID: 36602194 [No Abstract] [Full Text] [Related]
19. Formulation and evaluation of insulin dry powder for inhalation. Mahesh Kumar T; Misra A Drug Dev Ind Pharm; 2006 Jul; 32(6):677-86. PubMed ID: 16885123 [TBL] [Abstract][Full Text] [Related]
20. The development of dimple-shaped chitosan carrier for ethambutol dihydrochloride dry powder inhaler. Ahmad MI; Ungphaiboon S; Srichana T Drug Dev Ind Pharm; 2015 May; 41(5):791-800. PubMed ID: 24694185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]